Why Does Construction Sector Use Plasticizer-Based PVC?

The construction sector requires a large quantity of plasticizers due to the large-scale application of polyvinyl chloride (PVC) in the production of several building materials and tools. PVC products are used in the construction sector as they offer excellent resistance to ultraviolet (UV) light and temperature. PVC, in turn, requires plasticizers, such as dibutyl phthalate (DBP), diisononyl phthalate (DINP), dioctyl phthalate (DOP), and dioctyl terephthalate (DOTP), for softness. Thus, the expansion of the construction sector will accelerate the plasticizers market at a CAGR of 3.5% during 2019–2024. The market was valued at $13,967.9 million in 2018, and it is projected to reach $16,700.6 million by 2024.

There are majorly two types of plasticizers: phthalate and non-phthalate. Of these, the demand for the phthalate variants was higher in the past due to their large-scale consumption in the production of coatings, anti-viscosity agents, medical-grade plastics, and emulsifying agents. However, in the coming years, the consumption of non-phthalates is expected to rise faster on account of the toxic profile of certain phthalate plasticizers, which is why health concerns in developed economies have led to a ban on several key phthalate plasticizers.

To learn more about this report: https://bit.ly/2N1S83K

Currently, the plasticizers market is dominated by UPC Technology Corporation, a Taiwan-based company, which operates in China, the U.S., the Middle East, Southeast Asia, South Asia, Northeast Asia, and New Zealand. It offers basic plasticizers like DNOP, DOP, DINP, DOTP, DBIP, DPHP, DOA, TOTM, and TNTOM, as well as specialty plasticizers, in these regions and countries. Apart from this, key players such as LG Chem Ltd., BASF SE, Nan Ya Plastics Corporation, Eastman Chemical Company, KLJ Group, LANXESS AG, Evonik Industries AG, and Mitsubishi Chemical Corporation also manufacture all kinds of plasticizers to meet the growing demand.

Thus, the expansion of the construction and electrical and electronics sectors will amplify the usage of plasticizers in the coming years.

Share:

What Is Medical Sector’s Contribution to Graphene Market Growth?

Increasing applications of graphene in the medical and the electrical and electronics sectors will lead to the growth of the graphene market at a CAGR of 20.2% during the forecast period of 2020–2030. The market stood at $87.5 million in 2019, which is projected to reach $646.8 million by 2030. This can be attributed to the current market trend of product commercialization. Due to the easy availability of graphene and considerable research and development (R&D) to widen its applications, the compound is being used for the production of sports goods, conductive inks, digital displays, and automotive coatings.

Nevertheless, it is the medical sector that generates the maximum demand for graphene. The compound is widely used in the production of bioelectric sensors that are used in testing for deoxyribonucleic acid (DNA) and for tracking cholesterol, glucose, and hemoglobin, due to its thinness and high strength. Besides, graphene also finds applications in prosthesis devices, therapeutic tools, cancer treatment devices, and dental implants. In addition to these, researchers are combining graphene nanomaterials with nano adjuvants, vaccine carriers, and medications to increase the compatibility of these products with human immune cells.

To learn more about this report: https://bit.ly/3sQ2LWr

To garner maximum profits from this expanding market, industry players are focusing on product launches to widen their customer base and gain a competitive edge. ZEN Graphene Solutions Ltd., one of the key players in the graphene market, launched Albany Pure line of graphene products, in March 2020, to broaden its portfolio by adding graphene quantum dots, graphene oxide, and reduced graphene oxide. Similarly, Applied Graphene Materials plc. launched graphene products under the umbrella of Alltimes Coatings Advantage brand, in July 2019, to provide new roofing solution to industrial and commercial customers.

Thus, the widened application of graphene will significantly boost the market size during the forecast period.

Share:

Why Are Paper Materials Used for Tobacco Packaging in High Volume?

According to the World Health Organization (WHO), 1.337 billion people consumed tobacco in 2018 to deal with peer pressure and owing to personal views, the social and physical environment, and deteriorating mental health. The usage of tobacco-based products has surged among the working population as they help in relieving their stress. Tobacco contains nicotine, a psychoactive mood-altering chemical that stimulates dopamine release in the body, thus creating a sensation of relaxation and pleasure. Thus, the soaring consumption of tobacco will drive the tobacco packaging market at a CAGR of 3.7% during the forecast period (2020–2030), since generating $19,134.6 million in 2019.

To learn more about this report: https://bit.ly/3bYg6Fr

Different types of materials are used to pack tobacco leaves and tobacco-based end-products like shishas/waterpipes, bidis, cigarettes, cigars, and smokeless tobacco, to maintain their aroma and quality and protect them from natural degradation. Paper continues to be the most-popular packaging material due to the high consumption of cigarettes. The WHO states that 1 billion people used the nearly 6 trillion cigarettes produced in 2019. Moreover, the eco-friendly nature of paper and paperboard materials will accelerate their consumption in the tobacco industry. However, the usage of plastic packaging materials/containers is rising fast too, as they are lightweight and easily transportable.

According to P&S Intelligence, Asia-Pacific consumed the highest quantity of tobacco packaging materials in the past, and it will continue to do so in the foreseeable future. This can be primarily attributed to the presence of almost one-third of the world’s smokers in China. According to the WHO, China is home to nearly 300 million smokers. Moreover, the largescale production of cigarettes in China and technological advancements in the country are propelling the demand for the materials used in the primary and secondary packaging of tobacco products.

Thus, the booming number of smokers and e-cigarette users will fuel the usage of tobacco packaging materials in the coming years.

Share:

Which Application Segment will Dominate the Biopharmaceuticals Market in Future?

Biopharmaceutical products are pharmaceuticals that are derived from life forms, and they require a patent for exclusive manufacturing rights. These items are manufactured in a cleanroom ecosystem with set standards regarding airborne particles. These drugs can be nucleic acids, including deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and antisense oligonucleotides, and proteins, including antibodies. They are generally used for in vivo diagnostic and therapeutic purposes.

Biopharmaceuticals have proven effective in treating diseases such as neurological disorders, cancer, and infectious diseases. These products are useful in the management of several neurodegenerative disorders as these ailments require direct administration of a drug into the brain, which is not achievable with traditional medications. Moreover, the ongoing technological developments have been able to enhance the survival rate of patients suffering from life-threatening diseases like hepatitis and cancer. The World Health Organization (WHO) estimates that cancer accounts for around 9.6 million deaths each year, globally. Thus, the surging incidence of chronic disorders will augment the biopharmaceuticals market revenue

Therefore, with the increasing prevalence of cancer and CVDs, the requirement for biopharmaceuticals will rise in the foreseeable future. Additionally, the development of innovative and effective products and a soaring number of patent approvals to such pharmaceuticals will promote their administration, globally.

Share:

What are the Growth Projections for Dermatology Drugs Market in Emerging Countries?

The world has become a fashion show these days, with everyone vying to look their best. As a result, the aesthetics, cosmetics, and dermatology sectors are growing by leaps and bounds. Several diseases, environmental factors, age, and physical injuries can harm the appearance, by degrading the aesthetics of the skin. Thus, with their increasing appearance consciousness, coupled with their rising disposable income, people are spending more than before on themselves

As a result, P&S Intelligence says that the dermatology drugs market will likely grow to $55,425.0 million by 2030 from $25,228.2 million in 2019, at an 8.8% CAGR between 2020 and 2030. How common skin diseases are can be ascertained from the World Health Organization (WHO)’s data that claims that 900 million people are affected by such issues around the world at any time. Among these, scabies, pyoderma, eczema, acne, and warts are the most common, with acne affecting almost 80% of the U.S. population aged 12–24.

Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/dermatology-drug-market/report-sample

Apart from government organizations, pharmaceutical, medical device, and medical research companies are also taking initiatives to raise awareness on dermatological diseases around the world. For instance, Camp Wonder and Galderma S.A. have been partnering since 2012 to address children’s health needs. Some of the initiatives taken by these organizations are the Wonder Run 1K Waddle and 5K Run/Walk. Similarly, Kisaco Research conducted the Microbiome Connect Skin USA virtual summit in June 2020 to promote skin microbiome-based skincare products.

Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=dermatology-drug-market

Hence, as more people become aware of skin issues and the consciousness regarding appearance spreads to other regions, the demand for dermatology drugs is bound to rise.

Share:

Rising Size of Organic Farmlands Boosts Organic Fertilizers Market Growth

According to P&S Intelligence, the organic fertilizers market stood at $4,512.1 million in 2019 and it is expected to reach $14,746.2 million by 2030, accelerating at a CAGR of 14.1% during the forecast period (2020–2030). The market growth will depend on factors such as rising acreage and units of organically farmed areas, increasing support from governments in terms of initiatives and policies, and surging downstream demand for organic drinks and food.

To learn more about this report: https://bit.ly/2PyKI8Y

Escalating number and area of organic farmlands act as a catalyst for the organic fertilizers market growth. In recent years, there has been an exponential rise in size of organic farmlands, due the spurring downstream demand for organic products, on account of low chemical leaching during their cultivation and their health benefits. These factors eventually result in premium pricing and higher margins. Further, the increasing investments by private and public players in the organic food supply chain will lead to the high demand for organic fertilizers. 

Globally, Europe led the organic fertilizers market during the historical period (2015–2019). This is due to the fact that Europe has the largest area of organic arable land in the world and has been observing an increase in organic farming across numerous countries, including Italy, Germany, Spain, and Italy. Additionally, introduction and ratification of policies and legislations like the Common Agricultural Policy (CAP) and the EU Regulation 2018/848, high per capita spending, organized supply chain for the production-packaging-distribution model, and downstream retail demand for organic goods are fueling the regional market growth.

Thus, the expansion of organic farmland areas and the high demand for healthy food items, primarily in Europe and North America, will propel the market growth in the future.

Read More: https://www.psmarketresearch.com/market-analysis/organic-fertilizers-market-report

Share:

What are Factors Expected to Drive Progress of Automated Dispensing Machines Market in Asia-Pacific (APAC) in Future?

The surging incidence of medication errors is one of the major factors responsible for the increasing sales of automated dispensing machines across the globe. The prescription of inaccurate dosage of drugs to the patients is one of the major types of inpatient medication errors in healthcare settings and it has been found to cause adverse medication reactions and side effects in a large number of patients around the world. As per the National Center for Biotechnology Information (NCBI), nearly 7,000–9,000 deaths are caused due to medication errors in the U.S. every year.



The increasing incidence of chronic diseases is another important factor fuelling the rise in the demand for automated dispensing machines all over the world. The soaring incidence of cardiovascular and neurological diseases and cancer is boosting the requirement of drugs and also causing a huge spike in the hospitalization rates throughout the world. For example, as per the World Health Organization (WHO), 9.6 million people died because of cancer all over the globe in 2018 and cardiovascular diseases (CVDs) recorded for 31% of all the deaths in the world in 2016.

Owing to the above-mentioned reasons, the revenue generated from the global sales of automated dispensing machines is predicted to rise from $1.4 billion to $2.3 billion from 2018 to 2024. The global automated dispensing machines market is predicted to progress at a CAGR of 7.8% during the forecast period (2019—2024). There are mainly two types of automated dispensing machines used throughout the world— centralized and decentralized systems. Between the two, the decentralized systems are predicted to register faster growth in usage during the forecast period, primarily because of the increasing hospitalization rates all over the world. 

Automated dispensing machines are extensively used in out-patient and in-patient care. Of these, the usage of automated dispensing machines is expected to increase at a faster rate for in-patient care during the forecast period. This is due to the increasing incidence of chronic diseases across the world. Automated dispensing machines are adopted in pharmacies, retail drug stores, and hospitals. Amongst these, hospitals are expected to record the highest utilization of automated dispensing machines over the coming years, on account of the surging population of patients and rising healthcare expenditure in several countries all around the world. 

Therefore, the sales of automated dispensing machines is expected to surge throughout the world in the coming years, owing to the increasing geriatric population and the rising prevalence of chronic and cardiovascular diseases all over the world.


Share:

Popular Posts